PANOBINOSTAT for Plasma cell myeloma refractory: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 49 adverse event reports in the FDA FAERS database where PANOBINOSTAT was used for Plasma cell myeloma refractory.
Most Reported Side Effects for PANOBINOSTAT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 368 | 20.2% | 76 | 124 |
| Plasma cell myeloma | 279 | 15.3% | 170 | 80 |
| Platelet count decreased | 192 | 10.6% | 72 | 90 |
| Death | 190 | 10.4% | 189 | 17 |
| Malignant neoplasm progression | 166 | 9.1% | 104 | 61 |
| Fatigue | 162 | 8.9% | 28 | 46 |
| Nausea | 154 | 8.5% | 44 | 63 |
| Thrombocytopenia | 141 | 7.8% | 30 | 60 |
| Off label use | 112 | 6.2% | 37 | 9 |
| Vomiting | 109 | 6.0% | 20 | 60 |
| Drug ineffective | 105 | 5.8% | 46 | 18 |
| Pneumonia | 99 | 5.4% | 39 | 69 |
| Pyrexia | 98 | 5.4% | 40 | 65 |
| Anaemia | 95 | 5.2% | 39 | 49 |
| White blood cell count decreased | 83 | 4.6% | 35 | 49 |
Other Indications for PANOBINOSTAT
Plasma cell myeloma (1,262)
Product used for unknown indication (244)
Acute myeloid leukaemia (33)
Brain stem glioma (15)
Plasmacytoma (14)
Hodgkin's disease (13)
Plasma cell leukaemia (12)
Glioma (10)
Graft versus host disease (10)
Diffuse large b-cell lymphoma (8)
Other Drugs Used for Plasma cell myeloma refractory
DEXAMETHASONE (2,276)
POMALIDOMIDE (1,562)
LENALIDOMIDE (1,220)
CARFILZOMIB (1,208)
BORTEZOMIB (848)
DARATUMUMAB (789)
ISATUXIMAB (778)
CYCLOPHOSPHAMIDE (518)
IXAZOMIB (356)
DOXORUBICIN (314)